User profiles for Jeffrey Mahon
Jeffrey MahonVerified email at lhsc.on.ca Cited by 4360 |
The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results
JL Mahon, JM Sosenko, L Rafkin‐Mervis… - Pediatric …, 2009 - Wiley Online Library
Objectives: TrialNet’s goal to test preventions for type 1 diabetes has created an opportunity
to gain new insights into the natural history of pre‐type 1 diabetes. The TrialNet Natural …
to gain new insights into the natural history of pre‐type 1 diabetes. The TrialNet Natural …
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial–Type 1
…, JP Palmer, CJ Greenbaum, J Mahon… - Diabetes …, 2006 - Am Diabetes Assoc
OBJECTIVE—There is little information regarding the pattern of metabolic deterioration before
the onset of type 1 diabetes. The goal of this study was to utilize data from the Diabetes …
the onset of type 1 diabetes. The goal of this study was to utilize data from the Diabetes …
Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes: the TRIGR randomized clinical trial
Importance Early exposure to complex dietary proteins may increase the risk of type 1 diabetes
in children with genetic disease susceptibility. There are no intact proteins in extensively …
in children with genetic disease susceptibility. There are no intact proteins in extensively …
N-of-1 (Single-Patient) Trials for Statin-Related Myalgia
Background: Statin-related myalgia is difficult to distinguish from other conditions causing
myalgia and may often lead to statin discontinuation. Objective: To compare the effect of statin …
myalgia and may often lead to statin discontinuation. Objective: To compare the effect of statin …
Randomised study of n of 1 trials versus standard practice
J Mahon, A Laupacis, A Donner, T Wood - Bmj, 1996 - bmj.com
Objective: To compare outcomes between groups of patients with irreversible chronic airflow
limitation given theophylline by n of 1 trials or standard practice. Design: Randomised …
limitation given theophylline by n of 1 trials or standard practice. Design: Randomised …
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients
…, JP Palmer, JP Krischer, L Yu, J Mahon… - Diabetes …, 2013 - Am Diabetes Assoc
OBJECTIVE We assessed whether a risk score that incorporates levels of multiple islet
autoantibodies could enhance the prediction of type 1 diabetes (T1D). RESEARCH DESIGN AND …
autoantibodies could enhance the prediction of type 1 diabetes (T1D). RESEARCH DESIGN AND …
Health-related quality of life and mobility of patients awaiting elective total hip arthroplasty: a prospective study
Background: Waits for elective total hip arthroplasty for osteoarthritis are common in publicly
funded health care systems, but they may lead to poorer postoperative outcomes and loss of …
funded health care systems, but they may lead to poorer postoperative outcomes and loss of …
Natural course of remission in IDDM during 1st yr after diagnosis
…, AG Ziegler, T Mandrup-Poulsen, J Mahon - Diabetes …, 1992 - Am Diabetes Assoc
Objective –To describe the natural course of clinical remission in insulin-dependent diabetes
mellitus (IDDM) when insulin dose is minimized without loss of target glycemia and to …
mellitus (IDDM) when insulin dose is minimized without loss of target glycemia and to …
A risk score for type 1 diabetes derived from autoantibody-positive participants in the Diabetes Prevention Trial–Type 1
JM Sosenko, JP Krischer, JP Palmer, J Mahon… - Diabetes …, 2008 - Am Diabetes Assoc
OBJECTIVE—The accurate prediction of type 1 diabetes is essential for appropriately identifying
prevention trial participants. Thus, we have developed a risk score for the prediction of …
prevention trial participants. Thus, we have developed a risk score for the prediction of …
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2–therapy
Objective To update the evidence-based recommendations for the prevention and treatment
of hypertension in adults for 2010. Options and outcomes For lifestyle and pharmacological …
of hypertension in adults for 2010. Options and outcomes For lifestyle and pharmacological …